Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1641904,Alcrsp4,Alcohol response QTL 4,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),6,71206251,116206251,Rat,n/a,region,qtl 1000,738034,Anxrr5,Anxiety related response QTL 5,5.9,,exploratory behavior trait (VT:0010471),percentage of entries into a discrete space in an experimental apparatus (CMO:0000961),6,88507712,133507712,Rat,n/a,region,qtl 1000,1331799,Bp211,Blood pressure QTL 211,3.66407,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),6,75623277,136426962,Rat,n/a,region,qtl 1000,70196,BpQTLcluster7,Blood pressure QTL cluster 7,6.82,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),6,75623277,120623277,Rat,n/a,region,qtl 1000,1558641,Cm47,Cardiac mass QTL 47,2.9,0.001,heart mass (VT:0007028),heart wet weight (CMO:0000069),6,60606431,108154445,Rat,n/a,region,qtl 1000,6893332,Cm74,Cardiac mass QTL 74,0.4,0.64,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),6,60606431,108154445,Rat,n/a,region,qtl 1000,1576309,Emca7,Estrogen-induced mammary cancer QTL 7,4,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),6,2537030,111715717,Rat,n/a,region,qtl 1000,1300075,Glom7,Glomerulus QTL 7,5.6,0.0000002,kidney glomerulus morphology trait (VT:0005325),count of superficial glomeruli not directly contacting the kidney surface (CMO:0001002),6,75449871,120449871,Rat,n/a,region,qtl 1000,1300076,Glom8,Glomerulus QTL 8,7,0.000000009,kidney glomerulus morphology trait (VT:0005325),count of superficial glomeruli directly contacting the kidney surface (CMO:0001001),6,91703409,136703409,Rat,n/a,region,qtl 1000,10054138,Gmadr3,Adrenal mass QTL 3,3.68,0.00045,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),6,89631358,134631358,Rat,n/a,region,qtl 1000,737827,Hcar11,Hepatocarcinoma resistance QTL 11,4.4,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),6,86422697,115379601,Rat,n/a,region,qtl 1000,2293837,Kiddil1,Kidney dilation QTL 1,3.7,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),6,84763275,108464097,Rat,n/a,region,qtl 1000,2293842,Kiddil3,Kidney dilation QTL 3,4.3,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),6,84763275,108464097,Rat,n/a,region,qtl 1000,4145119,Mcs25,Mammary carcinoma susceptibility QTL 25,,0.0001,mammary gland integrity trait (VT:0010552),percentage of deaths in a study population during a period of time (CMO:0001024),6,7009971,115379601,Rat,n/a,region,qtl 1000,70176,Mcsm1,Mammary carcinoma susceptibility modifier QTL 1,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),6,62263348,107263348,Rat,n/a,region,qtl 1000,634330,Pia16,Pristane induced arthritis QTL 16,3.9,,joint integrity trait (VT:0010548),arthritic paw count (CMO:0001460),6,48432758,108268790,Rat,n/a,region,qtl 1000,4889848,Pur25,Proteinuria QTL 25,14,0.003,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),6,59803065,94001333,Rat,n/a,region,qtl 1000,1581550,Pur8,Proteinuria QTL 8,,,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),6,75623393,136142742,Rat,n/a,region,qtl 1000,1331789,Rf37,Renal function QTL 37,3.224,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),6,75623277,120276465,Rat,n/a,region,qtl 1000,1576302,Schws4,Schwannoma susceptibility QTL 4,,0.0078,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),6,87418448,111129520,Rat,n/a,region,qtl 1000,12801471,Schws9,Schwannoma susceptibility QTL 9,,,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),6,66129520,111129520,Rat,n/a,region,qtl 1000,10054123,Srcrt6,Stress Responsive Cort QTL 6,2.5,0.0043,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),6,89631358,134631358,Rat,n/a,region,qtl 1000,724513,Uae14,Urinary albumin excretion QTL 14,6.5,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,88996335,139410483,Rat,n/a,region,qtl 1000,724524,Uae2,Urinary albumin excretion QTL 2,2.7,0.0005,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,76902247,114203334,Rat,n/a,region,qtl 1000,731173,Uae22,Urinary albumin excretion QTL 22,10.1,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,68781170,147991367,Rat,n/a,region,qtl 1000,1581563,Uae33,Urinary albumin excretion QTL 33,,,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,75623393,136142742,Rat,n/a,region,qtl 1000,2290393,Uae37,Urinary albumin excretion QTL 37,,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),6,68781170,147991367,Rat,n/a,region,qtl 1000,724536,Uae7,Urinary albumin excretion QTL 7,3.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),6,75623277,136143011,Rat,n/a,region,qtl